medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2009, Number 4

<< Back Next >>

An Med Asoc Med Hosp ABC 2009; 54 (4)

Analysis of visceral adipose tissue by bioimpedance in overweight patients and their relationship with other indexes of insulin resistance

Hernández BME, Rojas JJA, Romero GR, Soriano SS

Language: Spanish
References: 18
Page: 193-196
PDF size: 58.95 Kb.


ABSTRACT

Background: Nowadays, obesity which is characterized by insulin resistance is directly related to metabolic syndrome. We determined the correlation between visceral fat mass measured by bioimpedance and other insulin resistance indexes in obese and overweight patients. Methods: We reviewed of 55 files of patients who went to internal medicine consultation between January 2007 and January 2008. In all the cases we looked for metabolic syndrome by ATP III criteria, we also documented corporal mass index, waist circumference, waist/hip ratio, HOMA index, and measurement of the subcutaneous and visceral fat mass by bioimpedance. We reviewed the correlation between the visceral fat mass and serum levels of insulin, glucose, triglycerides and high density lipoproteins. Results: We found a significant correlation between the visceral fat mass measured by bioimpedance and the waist/hip ratio (p ‹ 0.001), the corporal mass index (p‹ 0.001), waist circumference (p = 0.033), postprandial insulin (p = 0,047) and the presence of arterial systemic hypertension (p = 0.032). Conclusions: This study demonstrated that visceral fat mass measured by bioimpedance can be used as a screening test for the presence of insulin resistance in obese and overweight patients.


REFERENCES

  1. Reaven GM. Banting lecture. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.

  2. Lann D, LeRoith D. Insulin resistance as the underlying cause for the metabolic syndrome. Med Clin N Am 2007; 91: 1063-1077.

  3. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: A meta-analysis. Am J Med 2006; 119: 812-819.

  4. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III, ATP III) Final report. Circulation 2002; 106: 3143-3421.

  5. Gruñid S, Brewer B, Cleeman J, for the Conference Participants. Definition of Metabolic Syndrome. Report of the National Heart, Lung and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004; 109: 433-438.

  6. Basat O, Ucak S, Ozkurt H et al. Visceral adipose tissue as an indicator of insulin resistance in nonobese patients with new onset type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2006; 114 (2): 58-62.

  7. Schneider HJ, Glaesmer H, Klotsche J et al. Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab 2007; 92 (2): 589-594.

  8. Basat O, Ucak S, Ozkurt H et al. Visceral adipose tissue as an indicator of insulin resistance in nonobese patients with new onset type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2006; 114: 58-62.

  9. Bergman RN, Kim S, Hsu I et al. Abdominal obesity: Role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 2007; 120 (2a): S3-8.

  10. Rader DJ. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 2007; 120: S12-18.

  11. Wagenknecht LE, Langefeld CD, Scherzinger AL et al. Insulin sensitivity, insulin secretion, and abdominal fat: The Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2003; 52: 2490-2496.

  12. Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.

  13. Wallace TM, Levy JC, Matthews. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495.

  14. Chang A, Smith M, Bloem C et al. Limitation of the homeostasis model assessment to predict insulin resistance and b-cell dysfunction in older people. J Clin Endocrinol Metab 2006; 91: 629-634.

  15. Bloomgarden Z. Measures of insulin sensitivity. Clin Lab Med 2006; 26: 611-663.

  16. Cnop M, Landchild MJ, Vidal J et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: Distinct metabolic effects of two fat compartments. Diabetes 2002; 51: 1005-1015.

  17. Bosello O, Zamboni M. Visceral obesity and metabolic syndrome. Obes Rev 2000; 1: 47-56.

  18. Abate N, Garg A, Peshock RM et al. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96: 88-98.




2020     |     www.medigraphic.com